Simplex Trading’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Simplex Trading’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-194	Closed	-$344K	–	8375
2018 Q3	$344K	Buy	194 +126	+185%	+$2.16K	﹤0.01%	3019
2018 Q2	$93K	Sell	68 -829	-92%	-$9.84K	﹤0.01%	4387
2018 Q1	$52K	Buy	+897	New	+$4.95K	﹤0.01%	2414
2017 Q4	–	Sell	-97	Closed	-$12K	–	7166
2017 Q3	$12K	Buy	97 +23	+31%	+$32	﹤0.01%	3649
2017 Q2	$13K	Buy	+74	New	+$159	﹤0.01%	3785
2016 Q2	–	Sell	-79	Closed	-$19K	–	6826
2016 Q1	$19K	Buy	79 +27	+52%	+$88	﹤0.01%	2876
2015 Q4	$6K	Sell	52 -57	-52%	-$262	﹤0.01%	3804
2015 Q3	$24K	Buy	109 +18	+20%	+$94	﹤0.01%	2629
2015 Q2	$18K	Buy	91 +74	+435%	+$444	﹤0.01%	2586
2015 Q1	$11K	Sell	17 -44	-72%	-$254	﹤0.01%	2912
2014 Q4	$8K	Buy	+61	New	+$372	﹤0.01%	2792

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

Simplex Trading's ECYT Position: Q3 2018 in Review

Simplex Trading sold out of Endocyte, Inc. Common Stock (ECYT) in Q3 2018, closing a stake of 16,492 shares — an estimated $283K sold.

Simplex Trading first reported a position in ECYT in Q4 2014 and held it in 12 quarters. The position peaked at $227K in Q2 2018. 139 funds tracked by Wall St. Rank hold ECYT as of Q3 2018.

Simplex Trading reported no remaining Endocyte, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Simplex Trading sold 16,492 Endocyte, Inc. Common Stock shares in Q3 2018, an estimated $283K.
Simplex Trading first reported a position in Endocyte, Inc. Common Stock in Q4 2014 and held it in 12 quarters.
Simplex Trading's Endocyte, Inc. Common Stock position peaked at $227K in Q2 2018.
139 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2018.

Based on Simplex Trading's 13F filing for Q3 2018, filed 23 Oct 2018.